Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
BMC Infectious Diseases|September 3, 2022
A modified Sequential Organ Failure Assessment score for dengue: development, evaluation and proposal for use in clinical trialsAngela McBride, Nguyen Lam Vuong, Nguyen Van Hao, et al.Trials|July 13, 2019
Antibiotic Review Kit for Hospitals (ARK-Hospital): study protocol for a stepped-wedge cluster-randomised controlled trialAnn Sarah Walker, Eric Budgell, Magda Laskawiec-Szkonter, et al.The Lancet. Infectious Diseases|August 9, 2020
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort studyRichard Kuehl, Laura Morata, Christian Boeing, et al.Journal of Medical Microbiology|April 16, 2021
Co-infection in critically ill patients with COVID-19: an observational cohort study from EnglandVadsala Baskaran, Hannah Lawrence, Louise E Lansbury, et al.The Journal of Antimicrobial Chemotherapy|September 9, 2024
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19Jonathan A T Sandoe, Detelina Grozeva, Mahableshwar Albur, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 25, 2022
Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohortFrancesc Escrihuela-Vidal, Achim J Kaasch, Maja Von Cube, et al.Lancet (London, England)|December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.Journal of Thrombosis and Haemostasis : JTH|May 25, 2023
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trialPrapa Kanagaratnam, Darrel P Francis, Daniel Chamie, et al.Lancet (London, England)|December 5, 2021
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trialAlasdair P S Munro, Leila Janani, Victoria Cornelius, et al.Pageof 8